Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
426 participants
OBSERVATIONAL
2009-10-31
2012-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Whole-body MRI for the Detection of Metastasis
NCT02183597
Predicting Cancer Risk With Digital and Molecular Markers
NCT06962670
Use of Dynamic Contrast-Enhanced Magnetic Resonance Imaging to Assess Tumor-Associated Vasculature in Patients With Metastatic Breast Cancer
NCT00071357
The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer
NCT06698679
Praegnant Breast Cancer: Early/Advanced/Metastatic
NCT02338167
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
breast cancer patients
Venous blood sample
Collection of a venous blood sample to investigate metabolic changes in blood
lung cancer patients
Venous blood sample
Collection of a venous blood sample to investigate metabolic changes in blood
control subjects
Venous blood sample
Collection of a venous blood sample to investigate metabolic changes in blood
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Venous blood sample
Collection of a venous blood sample to investigate metabolic changes in blood
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Plasma glucose concentration ≥ 200 mg/dl
* Intake of medication at the day of investigation
* History/treatment of cancer in the previous 5 years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ziekenhuis Oost-Limburg
OTHER
Algemeen Ziekenhuis Vesalius
OTHER
Ziekenhuis Maas en Kempen
OTHER
Mariaziekenhuis Noord-Limburg
OTHER
Hasselt University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. dr. Michiel Thomeer
prof. dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michiel Thomeer, prof. dr.
Role: PRINCIPAL_INVESTIGATOR
Ziekenhuis Oost-Limburg
Kurt Baeten, dr.
Role: PRINCIPAL_INVESTIGATOR
Hasselt University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ziekenhuis Oost-Limburg
Genk, Limburg, Belgium
Hasselt University
Hasselt, Limburg, Belgium
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Louis E, Adriaensens P, Guedens W, Vanhove K, Vandeurzen K, Darquennes K, Vansteenkiste J, Dooms C, de Jonge E, Thomeer M, Mesotten L. Metabolic phenotyping of human blood plasma: a powerful tool to discriminate between cancer types? Ann Oncol. 2016 Jan;27(1):178-84. doi: 10.1093/annonc/mdv499. Epub 2015 Oct 20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09/046U
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.